The contents of pharmacist interventions, which were carried out by the ward pharmacists in their routine pharmacy service activities, were sorted and analyzed to evaluate the contributions of pharmacists. In the ward where pharmacists were stationed, there were a total of 196 cases of pharmacist intervention. The prescription was changed in 170 cases, giving a rate of prescription change of 86.7％. The breakdown of the pharmacist intervention was as follows:`e ‹cacy/safety'', 106 cases, followed by``dosage regimen'' (48 cases) and``compliance'' (10 cases). Cost savings achieved during the investigation period were calculated to be 440,639 yen, and cost avoidance was valued at 1,941,847 3,883,695 yen using the Diagnosis Procedure Combination (DPC). The results of the present investigation showed that pharmacists contribute to through not only their pharmacy services, but also through the promotion of proper drug use and risk management, thereby contributing to hospital management through cost savings and avoidance.
INTRODUCTION
EŠorts to quantify pharmaceutical services in terms of health economics are widespread in the United States. 1) The Department of Pharmacy at the Nippon Medical School Hospital (hereafter``the Hospital'') has reported with respect to the dispensing of injections up to the present time that medical expenses can be reduced when pharmacists are proactively involved in the appropriate use of medicines. 2)`M edication Management and Guidance''
(MMG) is a comprehensive area of hospital pharmacist activity unique to Japan that has as its goals the appropriate use of medicines, the improvement of patient service, and the bettering of team care. To reach these objectives, pharmacists involved in MMG give medication guidance to inpatients on the basis of medication records, manage medication in hospital wards, and provide information about medication to physicians and other medical staŠ. So understood, this duty is gaining recognition as one of the most important aspects of the pharmaceutical profession.
Currently, concrete outcomes of MMG reported in the literature are the improvement of patient satisfaction levels, the avoidance of adverse drug reaction, the increase of patient awareness and understanding of medication, and the improvement of drug compliance, in addition to the improvement of clinical ndings. 3 5) However, there are not yet any detailed investigations of the eŠect of MMG on medical expenses. The current paper reports on the eŠect that pharmacists' involvement in MMG for the appropriate use of medicines at the Hospital had on patient outcomes, and evaluates whether or not this type of service is valuable from a pharmacoeconomic perspective.
METHOD Data
An investigation was carried out on 196 Case Reports of Pharmacist Intervention dating from February 2004 to June 2005. These reports were collected by pharmacists, which were engaged in MMG of Nippon Medical School Hospital. The Case Report of Pharmacist Intervention was modiˆed in part from the case report used by Onda et al. 6 8) Intervention and Outcome Evaluation The 
Reduction in Medication Expenses
The reduction in medication-related expenses in cases where there was a post-intervention prescription change was calculated by multiplying the number of days of the prescription by the diŠerence between the prescription medication expense after the change and the prescription medication expense before the change (Reduction in medical expenses＝(prescription medication expense before change-prescription medication expense after change)×# of days of prescription). The reduction amount was calculated with the database program developed by Kobayashi et al. 9) Avoidance of Increased Medical Expenses The amount of medical expense avoided due to ward pharmacists' helping patients to avoid medicationrelated adverse drug reaction was evaluated with the comprehensive payment system (DPC: Diagnosis Procedure Combination). 2) For example, when incompatibilities arose due to the use of medicine when prescriptions had not being changed, or when medicines that were inappropriate for individual patients' age or condition were administered, and resulting side eŠects were discovered, the case may belong to the category DPC no. 161070 (Other Intoxication). When the side eŠects are treated, assuming that surgery is not performed and the hospital stay required for treatment is between 2 and 4 days, the medical expenses for that period can be calculated as follows:
Medical expenses＝2418 points×# of days×medical institution coe‹cient (1.1810 for the Hospital). The 2004 edition of the DPC and medical institution coe‹cients were used.
RESULTS

Content of Intervention and Outcomes
Of the 196 interventions studied, 170 resulted in prescription change, a rate of 86.7％. Among the medicines addressed in the interventions, 166 were oral/external, â gure amounting to 84.7％ of the total; 30, or 15.3％, were injections. A breakdown of intervention content appears in Table 1 . The 106 cases regarding``EŠec-tiveness and Safety'' were most numerous. Following this, there were 48 cases relating to``Usage and Dosage'' and 10 relating to``Compliance''.
Further classiˆcation and analysis of the results presented in Table 1 appear in Table 2 . In the``EŠec-tiveness and Safety'' category,``Duplicated prescriptions with drugs of similar type or eŠect,''``Appearance of side eŠects while taking medication,''`R ecommended change in prescription on basis of drug eŠectiveness evaluation,''and``Contraindication'' were the most commonly indicated items.
The outcomes of the various interventions are shown in Table 3 . In 120 cases, or more than half of all interventions, the``EŠect of intervention on the patient'' was judged as positive. With respect to the question of the``Importance of intervention,'' 34 cases were rated``A'', 71 were rated``B'', and 72 were rated``C''.
Reduction in Medication Expenses
Among the cases involving prescription change following intervention, 136 resulted in a diŠerence in medication expense. These amounted to an overall cost reduction of ¥440,639 (¥457,322 in decreases and ¥16,683 in increases) ( Table 4) . 
Avoidance of Increased Medical Expenses
The number of cases in which outcome evaluations indicated an avoidance of increased medical expenses was 34-the number of cases marked with a signiˆcance level of``A'' among the post-intervention prescription changes. When adverse drug reaction appeared, requiring a requisite hospital stay of between 2 and 4 days in cases of interventions with outcome evaluations of signiˆcance level``A'', a possible future increase of ¥1,941,847 to ¥3,883,695 in medical expenses was regarded as preventable through early intervention regarding the appropriate use of medicines (Table 5) . 
DISCUSSION
The breakdown of pharmacist interventions reveals that the number of cases responding to``EŠectiveness and Safety'' concerns was most numerous, followed by``Usage and Dosage'' and then``Compliance''. These data are illustrative of the fact that, in contrast to dispensing in the pharmacy, the consultations with patients and communication with ward staŠ required in MMG are relatively easy to perform. As a result, signiˆcant contributions would seem to be possible with respect to the appropriate use of medicines and the promotion of risk management in a manner that is responsive to individual patient conditions and compliance. Furthermore, the results of this investigation suggest that pharmacist intervention has a large in‰uence on medication: over 60％ of the prescription changes following pharmacist intervention were judged as having a positive eŠect on the patient, and clinically meaningful prescription changes (A＋B＋ C) amounted to over 90％ of the total. For these reasons, Pharmacist interventions with physicians may contribute to risk avoidance and the appropriate use of medicines through MMG.
Theˆndings also clearly indicate that the cost beneˆts of MMG are not just realized in terms of consultation fees, but also signiˆcantly in the reduction of medication costs and avoidance of increases in medical expenses. In turn, these results suggest that pharmacists are making contributions to hospital administration through the appropriate use of medicines. In particular, research such as the present study, through investigation and substantiation of the cost beneˆts that accrue to the avoidance of medical expenses, will likely play an important part in realizing a broader social appreciation of hospital pharmacists' professional abilities.
As pharmacists, we are signiˆcantly contributing to patients' safety management through the appropriate use of medicines. However, evaluation of this service from the perspective of health economics, and the corresponding level of contribution to hospital administration, have not yet been actively discussed. The group that most centrally engaged in investigating placement standards for hospital pharmacists is medical management organizations. For this reason, one of the most important factors in‰uencing future evaluations of pharmacists' service will be showing clearly to managers, in numerical form, to what degree we are contributing to hospital administration through our role in the appropriate use of medicines. Thus, by understanding pharmacoeconomics and implementing its analytical methods in decision-making processes and the medication evaluations that inform them, pharmacists will be able to expand the scope of their in‰uence with respect to both the quality of medication and hospital management.
